⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10816942 | 0.69 | — | — | |
| SCHEMBL9846334 | 0.69 | — | — | |
| SCHEMBL14733248 | 0.67 | MEN1 (0.31) | — | |
| SCHEMBL31275546 | 0.65 | — | — | |
| SCHEMBL15667194 | 0.65 | — | — | |
| SCHEMBL13380978 | 0.65 | — | — | |
| SCHEMBL5597740 | 0.65 | — | — | |
| SCHEMBL2573920 | 0.65 | — | — | |
| SCHEMBL17931768 | 0.62 | — | — | |
| SCHEMBL4966253 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2072515-B1 | Substituted quinazolidines for antidiabetic treatment | 55PHARMA DRUG DISCOVERY & DEV AG (AT) | 2011-08-31 | — | — | EP | claimed |
| EP-1404324-B1 | PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF | XENOPORT INC (US) | 2007-12-05 | — | — | EP | claimed |
| EP-0548285-B1 | FUNGICIDAL 3,3-BIS[ALKYLTHIO]-2-PYRIDYLACRYLIC ACID DERIVATIVES | UNIROYAL CHEM CO INC (US) | 1995-10-18 | — | — | EP | claimed |
| WO-2008083280-A1 | COMPOUNDS AND METHODS OF TREATING INSULIN RESISTANCE AND CARDIOMYOPATHY | TRANSITION THERAPEUTICS INC. (CA) | 2008-07-10 | — | — | WO | disclosed |
| US-20080139455-A1 | COMPOUNDS AND METHODS OF TREATING METABOLIC SYNDROME AND INFLAMMATION | FORBES MEDI-TECH (RESEARCH), INC. (US) | 2008-06-12 | — | — | US | disclosed |
| WO-2008046071-A2 | COMPOUNDS AND METHODS OF TREATING METABOLIC SYNDROME AND INFLAMMATION | TRANSITION THERAPEUTICS INC. (CA) | 2008-04-17 | — | — | WO | disclosed |